Lactate dehydrogenase predicts combined progression-free survival after sequential therapy with abiraterone and enzalutamide for patients with castration-resistant prostate cancer.
| Image |  |
|---|---|
| Description | scientific article published on 30 May 2017 |
| Author/s |
author: Keiichiro Mori |
| Publication date | May 30, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |